(Total Views: 462)
Posted On: 09/20/2021 9:01:08 PM
Post# of 145873
I just have to say I am liking you more and more for switching to this chat board. Saying 4 fingers in value is right in my wheel house… I have been preaching the same for a long time… the future is so bright. We just need a break to kick start our ascent to the big times. First EUA gets us that kick start.
The only draw back has been this pesky 13d group that can go screw off. If you don’t know by now they are not here to help the average stockholder then you have been asleep at the wheel and spinning out of control. The 13d group could sink us and stop our ascent into revenue. We can’t let that happen. Vote our management and BOD candidates for keeping our path on growing into our very own pharmaceutical company.
Once we achieve revenue we can have real trials of size that can’t be disputed and then Nash and Cancer will show just how effective Leronlimab is. Then we trial 10 new indications in 2022. MS and other autoimmune diseases are high on the list to trial. Maybe a basket trial is possible for autoimmune diseases? Maybe ohm can figure an angle that gets us half of the 100+ autoimmune diseases all in one cost saving trial? Wouldn’t that be sweet for those people in need and for the stockholders too…
I see a huge amount of speculation last few days and it’s refreshing change from all the 13d bummer BS. The sooner they are out of the picture the sooner our lives turn to all positives. Thats how I see it. I am ready to ride that wave of optimism now. We are well on our way to great times. Hoping for a great October 6th!
The only draw back has been this pesky 13d group that can go screw off. If you don’t know by now they are not here to help the average stockholder then you have been asleep at the wheel and spinning out of control. The 13d group could sink us and stop our ascent into revenue. We can’t let that happen. Vote our management and BOD candidates for keeping our path on growing into our very own pharmaceutical company.
Once we achieve revenue we can have real trials of size that can’t be disputed and then Nash and Cancer will show just how effective Leronlimab is. Then we trial 10 new indications in 2022. MS and other autoimmune diseases are high on the list to trial. Maybe a basket trial is possible for autoimmune diseases? Maybe ohm can figure an angle that gets us half of the 100+ autoimmune diseases all in one cost saving trial? Wouldn’t that be sweet for those people in need and for the stockholders too…
I see a huge amount of speculation last few days and it’s refreshing change from all the 13d bummer BS. The sooner they are out of the picture the sooner our lives turn to all positives. Thats how I see it. I am ready to ride that wave of optimism now. We are well on our way to great times. Hoping for a great October 6th!
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)